The Ethical, Legal and Regulatory Issues Associated with Pharmacogenomics: Systematically Quantifying the Literature

View/ Open
File version
Version of Record (VoR)
Author(s)
Hewitt, Jayne E
Griffith University Author(s)
Year published
2018
Metadata
Show full item recordAbstract
Since the human genome was successfully mapped much academic attention
has been given to ethical, legal and regulatory issues associated with the
integration and application of genomics in health care. In line with the recent
political commitment to promoting precision medicine that relies heavily on
“omic knowledge”, it is timely to review the issues that this body of literature
has addressed. Focusing on “pharmacogenomics”, this review quantifies the
issues identified in this body of academic work. It reveals that, after nearly
two decades, interest in the regulatory and legal issues associated with
pharmacogenomics continues ...
View more >Since the human genome was successfully mapped much academic attention has been given to ethical, legal and regulatory issues associated with the integration and application of genomics in health care. In line with the recent political commitment to promoting precision medicine that relies heavily on “omic knowledge”, it is timely to review the issues that this body of literature has addressed. Focusing on “pharmacogenomics”, this review quantifies the issues identified in this body of academic work. It reveals that, after nearly two decades, interest in the regulatory and legal issues associated with pharmacogenomics continues to generate significant attention. The ethical issues, while not as predominant, also persist. The analyses highlights that there is a dearth of empirical research exploring the impact that these issues have had.
View less >
View more >Since the human genome was successfully mapped much academic attention has been given to ethical, legal and regulatory issues associated with the integration and application of genomics in health care. In line with the recent political commitment to promoting precision medicine that relies heavily on “omic knowledge”, it is timely to review the issues that this body of literature has addressed. Focusing on “pharmacogenomics”, this review quantifies the issues identified in this body of academic work. It reveals that, after nearly two decades, interest in the regulatory and legal issues associated with pharmacogenomics continues to generate significant attention. The ethical issues, while not as predominant, also persist. The analyses highlights that there is a dearth of empirical research exploring the impact that these issues have had.
View less >
Journal Title
Journal of Law and Medicine
Volume
25
Publisher URI
Copyright Statement
© 2018 Thomson Reuters. This article was first published by Thomson Reuters in the Journal of Law and Medicine and should be cited as Jayne E Hewitt, The Ethical, Legal and Regulatory Issues Associated with Pharmacogenomics: Quantifying the Literature, (2018) 25 JLM 782. For all subscription inquiries please phone, from Australia: 1300 304 195, from Overseas: +61 2 8587 7980 or online at legal.thomsonreuters.com.au/search. The official PDF version of this article can also be purchased separately from Thomson Reuters at http://sites.thomsonreuters.com.au/journals/subscribe-or-purchase.
Subject
Biomedical and clinical sciences
Philosophy and religious studies